FTC Clears Takeda's Acquisition of Shire

Takeda Pharmaceutical Company Limited (“Takeda”) announce on 7/10/18 that it has received unconditional clearance from the United States Federal Trade Commission (“FTC”) for the proposed acquisition of Shire plc announced on May 8, 2018 (the “Acquisition”).